< Back to previous page

Publication

Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia.

Journal Contribution - Journal Article

Journal: Nature cancer

Volume: 2

Pages: 1204-1223

Publication year:2021

DOI: https://doi.org/10.1038/s43018-021-00264-y

Accessibility:Closed

See also: Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia